These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T and B markers in immunodeficiencies. Griscelli C Birth Defects Orig Artic Ser; 1975; 11(1):45-9. PubMed ID: 1096991 [No Abstract] [Full Text] [Related]
4. Disorders of host defense against infection. Pathophysiologic and diagnostic considerations. Johnston RB; Lawton AR; Cooper MD Med Clin North Am; 1973 Mar; 57(2):421-40. PubMed ID: 4571800 [No Abstract] [Full Text] [Related]
5. Subpopulations of human T lymphocytes. V. T lymphocytes with receptors for immunoglobulin M or G in patients with primary immunodeficiency disorders. Gupta S; Good RA Clin Immunol Immunopathol; 1978 Nov; 11(3):292-302. PubMed ID: 309372 [No Abstract] [Full Text] [Related]
7. A conceptual approach to immunodeficiency. Bardana EJ Med Clin North Am; 1981 Sep; 65(5):959-76. PubMed ID: 7026918 [TBL] [Abstract][Full Text] [Related]
8. The primary immunodeficiency diseases: classification, pathogenesis and treatment. Gatti RA; Seligmann M Turk J Pediatr; 1973 Oct; 15(4):195-215. PubMed ID: 4600502 [No Abstract] [Full Text] [Related]
13. The pathogenesis and treatment of immunodeficiency. Horowitz SD; Hong R Monogr Allergy; 1977; 10():1-198. PubMed ID: 327292 [No Abstract] [Full Text] [Related]
14. Activation of T-cells rosettes in immunodeficient patients by thymosin. Wara DW; Ammann AJ Ann N Y Acad Sci; 1975 Feb; 249():308-15. PubMed ID: 1079429 [No Abstract] [Full Text] [Related]
16. Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease. Ann Intern Med; 1972 Oct; 77(4):605-28. PubMed ID: 4581908 [No Abstract] [Full Text] [Related]